© 1992 Oxford University Press
other |
Aflatoxrn M1 in human breast milk from The Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC
Department of Environmental Health Sciences, The Johns Hopkins University School of Hygiene and Public Health 615 North Wolfe Street, Baltimore, MD 21205, USA
1International Agency for Research on Cancer 150 cours Albert Thomas, 69372 Cedex 08, Lyon. France
2Medical Research Council Dunn Nutrition Unit, Milton Road, Cambridge CB4 1XJ, UK
Maternal to child exposure of aflatoxin M1 in breast milk is an underevaluated risk factor from dietary exposure to aflatoxin B1. A molecular dosimetry study in The Gambia, West Africa, was initiated to explore the relationships between dietary intake of aflatoxins during a 1 week period and a number of aflatoxin biomarkers including aflatoxin metabolite excretion into breast milk. For the breast milk study, five lactating women were identified and milk samples were collected by hand expression once a day during days 37 for three women and during days 36 for the two other women. Afiatoxin M1 (AFM1) in human milk was measured in all five subjects by a preparative monoclonal antibody imniunoaffinity column/HPLC method. In three of the five women, aflatoxin G1 was found. Estimates of the percentage of aflatoxin in the diet excreted as AFM1 in milk ranged from 0.09 to 0.43%. Thus, these data indicate that a rapid methodology exists to assess the levels of AFM1 excretion in human milk and to use this approach as a biomarker for exposure of children to this carcinogen.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. C Turner, A. C Collinson, Y. B. Cheung, Y. Gong, A. J Hall, A. M Prentice, and C. P Wild Aflatoxin exposure in utero causes growth faltering in Gambian infants Int. J. Epidemiol., October 1, 2007; 36(5): 1119 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kirk, E. Bah, and R. Montesano Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E.v. Herwaarden, E. Wagenaar, B. Karnekamp, G. Merino, J. W. Jonker, and A. H. Schinkel Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk Carcinogenesis, January 1, 2006; 27(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H Williams, T. D Phillips, P. E Jolly, J. K Stiles, C. M Jolly, and D. Aggarwal Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1106 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gong, S Egal, A Hounsa, P. Turner, A. Hall, K. Cardwell, and C. Wild Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning Int. J. Epidemiol., August 1, 2003; 32(4): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Drugs The Transfer of Drugs and Other Chemicals Into Human Milk Pediatrics, September 1, 2001; 108(3): 776 - 789. [Abstract] [Full Text] [PDF] |
||||



